Semaglutide is a medication used in the treatment of type 2 diabetes and obesity. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. These medications work by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels and promotes feelings of fullness after eating, leading to weight loss.
In addition to its use in diabetes management, semaglutide has also been approved by the FDA for the treatment of obesity in adults with a BMI (body mass index) of 30 or higher, or with a BMI of 27 or higher and at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol).
It's important to note that semaglutide, like any medication, may have side effects and should be used under the guidance of a healthcare professional. Common side effects may include nausea, vomiting, diarrhea, and abdominal pain.
| Product Name | Semaglutide Peptide |
|---|---|
| Storage Conditions | Store At 2-25°C |
| Test Method | HPLC UV |
| Form | 99% Raw Powder |
| COA | Available |
| Indication | Weight Loss |
| Shelf Life | 2 Years |
| CAS | 910463-68-2 |
| Active Ingredient | Semaglutide |
| Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
1. Type 2 Diabetes Management: Semaglutide is primarily used in the treatment of type 2 diabetes. It belongs to the class of medications known as GLP-1 receptor agonists. By mimicking the action of the natural hormone GLP-1, semaglutide helps regulate blood sugar levels in people with type 2 diabetes. It stimulates insulin release from pancreatic cells, reduces glucagon secretion, slows down stomach emptying, and promotes a feeling of fullness after meals. These effects collectively contribute to better glycemic control.
2. Weight Management: In addition to its role in diabetes management, semaglutide has been approved for the treatment of obesity in adults. Obesity is a complex condition with multiple contributing factors, and semaglutide can aid weight loss efforts by reducing appetite and calorie intake. It is usually prescribed in conjunction with lifestyle modifications such as a healthy diet and regular exercise.
3. Cardiovascular Risk Reduction: Studies have shown that semaglutide may have additional benefits beyond glucose control and weight loss. It has been associated with reductions in cardiovascular risk factors such as blood pressure and cholesterol levels. These cardiovascular benefits are particularly relevant for individuals with type 2 diabetes who are at increased risk of heart disease and stroke.
3. Alzheimer's Disease: While not a primary application, there is also ongoing research exploring the potential neuroprotective effects of GLP-1 receptor agonists like semaglutide in conditions such as Alzheimer's disease and other neurodegenerative disorders. These studies aim to understand whether these medications could help protect neurons and improve cognitive function.
